Get the Stockscreener App
308.06
0.73%
2.24
After Hours:
308.06
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $308.06, with a volume of 2.84M.
It is up +0.73% in the last 24 hours and up +7.93% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$305.82
Open:
$308.51
24h Volume:
2.84M
Relative Volume:
0.83
Market Cap:
$165.25B
Revenue:
$33.42B
Net Income/Loss:
$4.09B
P/E Ratio:
40.80
EPS:
7.55
Net Cash Flow:
$10.39B
1W Performance:
+1.67%
1M Performance:
+7.93%
6M Performance:
-7.72%
1Y Performance:
+12.50%
1-Day Range:
$303.52
$308.62
1-Week Range:
$303.10
$318.30
52-Week Range:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
308.06 | 165.25B | 33.42B | 4.09B | 10.39B | 7.55 |
|
LLY
Lilly Eli Co
|
920.63 | 874.97B | 45.04B | 10.59B | 414.30M | 11.71 |
|
NVO
Novo Nordisk Adr
|
90.65 | 402.40B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
ABBV
Abbvie Inc
|
209.03 | 369.01B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
165.02 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
MRK
Merck Co Inc
|
92.25 | 251.88B | 64.17B | 17.12B | 18.10B | 6.73 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Mn Services Vermogensbeheer B.V. Grows Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Position Lowered by Modera Wealth Management LLC - MarketBeat
Connable Office Inc. Sells 1,288 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Nichols & Pratt Advisers LLP MA - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Bailard Inc. - MarketBeat
1,064 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Hickory Point Bank & Trust - MarketBeat
PCG Asset Management LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
US Bancorp DE Reduces Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Kinsale Capital Group Inc. Buys 3,047 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Gulf International Bank UK Ltd Sells 1,041 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Capital Wealth Planning LLC Acquires 154,341 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Fisher Asset Management LLC - MarketBeat
Zacks Research Comments on Amgen's Q1 Earnings (NASDAQ:AMGN) - MarketBeat
International Myeloma Foundation (IMF) Celebrates Myeloma Milestones for 2025 Myeloma Action Month - GlobeNewswire Inc.
Zacks Research Brokers Boost Earnings Estimates for Amgen - MarketBeat
SVB Wealth LLC Makes New $6.75 Million Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Mutual of America Capital Management LLC Has $16.82 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Flputnam Investment Management Co. Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Red Crane Wealth Management LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amalgamated Bank Sells 3,948 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sabal Trust CO Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
ARK Investment Management LLC Has $17.30 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
National Pension Service Increases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Advisor OS LLC Grows Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Fortress Financial Group LLC Purchases Shares of 2,910 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Traders Purchase High Volume of Call Options on Amgen (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by First American Bank - MarketBeat
Union Bancaire Privee UBP SA Acquires Shares of 2,647 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Illinois Municipal Retirement Fund Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025 - Insider Monkey
Can Amgen's R&D Chief Signal New Breakthroughs at Upcoming Healthcare Conference? - StockTitan
Why Amgen Inc. (AMGN) is the Best Vaccine Stock to Buy According to Hedge Funds? - Insider Monkey
QRG Capital Management Inc. Reduces Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Consilium Wealth Advisory LLC Lowers Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc: An Exploration into Its Intrinsic Value - GuruFocus.com
Proficio Capital Partners LLC Acquires 469,470 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Fort Sheridan Advisors LLC Purchases 916 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Lessened by Peloton Wealth Strategists - MarketBeat
Los Angeles Capital Management LLC Cuts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Empowering Change: Addressing Cardiovascular Risk in Underserved Communities Through Clinical Research - Amgen
Oppenheimer & Co. Inc. Has $28.98 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Melanoma Therapeutics Market Growth, Trends, and Key Players 2025-2033 | Amgen, Inc., Novartis AG, Pfizer Inc. - openPR
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Lineweaver Wealth Advisors LLC - MarketBeat
Oncology Biosimilars Market Projected To Witness Substantial Growth, 2025-2032: Amgen Inc., Allergan, Plc, - EIN News
Nwam LLC Sells 2,654 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
NewEdge Wealth LLC Purchases 9,113 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Apple, Amgen share losses lead Dow's 175-point drop - MSN
Rothschild Investment LLC Acquires 1,642 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Increased by Y Intercept Hong Kong Ltd - MarketBeat
Red Biotechnology Market Growth and Future Scope 2025-2032 | Amgen Inc., Gilead Sciences, Inc., Biogen - openPR
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Amgen Inc Stock (AMGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations |
Feb 19 '25 |
Sale |
292.84 |
8,711 |
2,550,903 |
71,546 |
| REESE DAVID M | EVP & Chief Technology Officer |
Feb 19 '25 |
Option Exercise |
156.35 |
8,711 |
1,361,965 |
70,858 |
| REESE DAVID M | EVP & Chief Technology Officer |
Feb 21 '25 |
Sale |
304.44 |
25,225 |
7,679,524 |
36,922 |
| REESE DAVID M | EVP & Chief Technology Officer |
Feb 19 '25 |
Sale |
293.22 |
8,711 |
2,554,224 |
62,147 |
1.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):